Olivier Taelman
Chief Executive Officer presso NYXOAH SA
Patrimonio netto: 6 M $ in data 31/03/2024
Profilo
Olivier Taelman is currently the Chief Executive Officer & Executive Director at Nyxoah SA. Prior to his current position, he worked as the Business Director-Neuromodulation at Nevro Corp.
from 2013 to 2015, and as the Vice President-Europe at Autonomic Technologies, Inc. from 2015 to 2019.
Mr. Taelman completed his undergraduate degree at Hasselt University and holds an MBA from The Wharton School of the University of Pennsylvania.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
NYXOAH SA
1.47% | 18/03/2024 | 419 930 ( 1.47% ) | 6 M $ | 31/03/2024 |
Posizioni attive di Olivier Taelman
| Società | Posizione | Inizio |
|---|---|---|
| NYXOAH SA | Chief Executive Officer | 01/11/2019 |
Precedenti posizioni note di Olivier Taelman
| Società | Posizione | Fine |
|---|---|---|
Autonomic Technologies, Inc.
 Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | Corporate Officer/Principal | 01/11/2019 |
| NEVRO CORP. | Corporate Officer/Principal | 01/12/2015 |
Formazione di Olivier Taelman
| Hasselt University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| NEVRO CORP. | Health Technology |
| NYXOAH SA | Health Technology |
| Aziende private | 1 |
|---|---|
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | Electronic Technology |
- Borsa valori
- Insiders
- Olivier Taelman
